Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

395 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cochlear dysfunction as an early biomarker of cognitive decline in normal hearing and mild hearing loss.
Medel V, Delano PH, Belkhiria C, Leiva A, De Gatica C, Vidal V, Navarro CF, Martín SS, Martínez M, Gierke C, García X, Cerda M, Vergara R, Delgado C, Farías GA. Medel V, et al. Among authors: vidal v. Alzheimers Dement (Amst). 2024 Feb 1;16(1):e12467. doi: 10.1002/dad2.12467. eCollection 2024 Jan-Mar. Alzheimers Dement (Amst). 2024. PMID: 38312514 Free PMC article.
Author Correction: The BrainLat project, a multimodal neuroimaging dataset of neurodegeneration from underrepresented backgrounds.
Prado P, Medel V, Gonzalez-Gomez R, Sainz-Ballesteros A, Vidal V, Santamaría-García H, Moguilner S, Mejia J, Slachevsky A, Behrens MI, Aguillon D, Lopera F, Parra MA, Matallana D, Maito MA, Garcia AM, Custodio N, Funes AÁ, Piña-Escudero S, Birba A, Fittipaldi S, Legaz A, Ibañez A. Prado P, et al. Among authors: vidal v. Sci Data. 2024 Jan 2;11(1):19. doi: 10.1038/s41597-023-02870-0. Sci Data. 2024. PMID: 38168123 Free PMC article. No abstract available.
The BrainLat project, a multimodal neuroimaging dataset of neurodegeneration from underrepresented backgrounds.
Prado P, Medel V, Gonzalez-Gomez R, Sainz-Ballesteros A, Vidal V, Santamaría-García H, Moguilner S, Mejia J, Slachevsky A, Behrens MI, Aguillon D, Lopera F, Parra MA, Matallana D, Maito MA, Garcia AM, Custodio N, Funes AÁ, Piña-Escudero S, Birba A, Fittipaldi S, Legaz A, Ibañez A. Prado P, et al. Among authors: vidal v. Sci Data. 2023 Dec 9;10(1):889. doi: 10.1038/s41597-023-02806-8. Sci Data. 2023. PMID: 38071313 Free PMC article.
Regorafenib in patients with advanced Ewing sarcoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre Phase II study.
Duffaud F, Blay JY, Le Cesne A, Chevreau C, Boudou-Rouquette P, Kalbacher E, Penel N, Perrin C, Laurence V, Bompas E, Saada-Bouzid E, Delcambre C, Bertucci F, Cancel M, Schiffler C, Monard L, Bouvier C, Vidal V, Gaspar N, Chabaud S. Duffaud F, et al. Among authors: vidal v. Br J Cancer. 2023 Dec;129(12):1940-1948. doi: 10.1038/s41416-023-02413-9. Epub 2023 Nov 1. Br J Cancer. 2023. PMID: 37914801 Clinical Trial.
395 results